U.S. Stock News

NasdaqGM:OMER
NasdaqGM:OMERPharmaceuticals

Assessing Omeros (OMER) Valuation After Recent Share Price Rebound And Novo Nordisk Deal Prospects

What recent performance signals for Omeros (OMER) Without a single defining headline driving trading, Omeros (OMER) has still drawn attention after a strong month and past 3 months, alongside sizeable 1 year and 3 year total returns. At a recent price of $14.83 and a market cap of about $1.06b, the stock reflects a clinical stage pipeline built around immunologic and rare disease programs rather than current product revenue. See our latest analysis for Omeros. For context, Omeros has paired a...
NYSE:MP
NYSE:MPMetals and Mining

Is It Too Late To Consider MP Materials (MP) After Rare Earth Supply Chain Tailwinds?

To figure out whether MP Materials stock still offers value after its strong run, you need to separate a compelling story about rare earths from what the current share price already reflects. The stock last closed at US$72.65, with returns of 18.5% over 7 days, 42.0% over 30 days, 32.2% year to date, 207.6% over 1 year, 221.7% over 3 years and 192.9% over 5 years, so recent performance is front of mind for many investors. Recent news around rare earth supply chains and US focused production...
NasdaqGS:ASO
NasdaqGS:ASOSpecialty Retail

Is It Too Late To Consider Academy Sports and Outdoors (ASO) After Strong Five Year Return?

Wondering whether Academy Sports and Outdoors at around US$54.46 is still priced attractively, or if most of the easy upside is gone? This article focuses squarely on what the numbers say about value. The stock has returned 4.4% year to date and 36.7% over the past year, while the past 30 days and 7 days show declines of 4.8% and 0.7%. This can change how the market is thinking about risk and opportunity. Recent coverage around Academy Sports and Outdoors has centered on how the business is...
NYSE:ITT
NYSE:ITTMachinery

ITT (ITT) Q1 Margin Compression Tests Bullish Growth Narrative

ITT (ITT) opened 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$0.89, setting the tone for how the year could unfold against its recent track record. The company has seen quarterly revenue move from US$913 million in Q1 2025 to US$1.2 billion in Q1 2026, while basic EPS ranged from US$1.33 in Q1 2025 to US$1.65 in Q4 2025 before the latest Q1 print. This puts the focus firmly on how much of this top line is flowing through to margins. See our full analysis for ITT. With the latest...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Has The Recent Pullback In Zoetis (ZTS) Opened A New Valuation Opportunity?

If you are wondering whether Zoetis at around US$111 is a bargain or a value trap, this article will explain what the current price might be implying about the stock. The stock has recently retreated, with returns of 2.3% over 7 days, 6.0% over 30 days, 11.7% year to date, and 27.6% over 1 year. This may have shifted how the market views its risk and reward trade off. Recent coverage has focused on Zoetis as a major animal health company, highlighting how the sector can be influenced by...
NasdaqCM:PHOE
NasdaqCM:PHOEConstruction

Assessing Phoenix Asia Holdings (NasdaqCM:PHOE) Valuation After Sharp Short Term Share Price Swings

Phoenix Asia Holdings (PHOE) has drawn fresh attention after recent trading, with the stock last closing at $28.60. Investors are weighing its substructure construction focus in Hong Kong against recent short term share price moves. See our latest analysis for Phoenix Asia Holdings. The recent 1 day share price return of 39.14% decline contrasts sharply with the 7 day share price return of 83.92% and the year to date share price return of 76.11%. The 1 year total shareholder return is very...
NYSE:NABL
NYSE:NABLSoftware

Assessing N-able (NABL) Valuation After Narrower Q1 2026 Net Loss Draws Fresh Investor Attention

Q1 earnings highlight a narrower loss N-able (NABL) reported first quarter 2026 earnings with a net loss of US$615,000, compared with a net loss of US$7.16 million a year earlier, drawing fresh attention to the stock. See our latest analysis for N-able. The earnings update comes after a mixed share price stretch, with a 10.17% 1 month share price return, a 27.26% year to date share price decline, and a 25.63% 1 year total shareholder return loss, suggesting momentum has been weak despite...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Ouster (OUST) Q1 Loss Resurfacing After Q4 Profit Tests Bullish Profitability Narrative

Ouster (OUST) opened 2026 with Q1 revenue of US$48.6 million and a basic EPS loss of US$0.28, alongside a net loss of US$17.5 million. On a trailing 12 month basis, revenue sits at US$185.3 million and basic EPS is a loss of US$0.95 against a net loss of US$55.8 million. Over the past reported quarters, revenue has moved from US$30.1 million in Q4 2024 to US$32.6 million in Q1 2025 and then to US$48.6 million in Q1 2026, with quarterly EPS losses ranging between US$0.48 and US$0.28 across...
NYSE:INGM
NYSE:INGMElectronic

Ingram Micro Balances Share Sale With Buyback And Cybersecurity Expansion

Ingram Micro Holding (NYSE:INGM) is seeing a substantial secondary offering by its principal shareholder, an affiliate of Platinum Equity, shifting a meaningful block of ownership. The company has authorized a $30 million share repurchase from the underwriters in connection with this offering, signaling active capital management around the transaction. Separately, Ingram Micro has been selected as a global distribution partner for Huntress, a cybersecurity platform, expanding its reach in...
NYSE:CBT
NYSE:CBTChemicals

Is It Time To Reassess Cabot (CBT) After Its Recent Share Price Strength?

If you are wondering whether Cabot is trading at an attractive price today, or if the recent enthusiasm already reflects its value, this breakdown will help you put the current share price in context. Cabot's stock recently closed at US$82.41, with returns of 8.8% over the past week, 10.8% over the past month, 22.9% year to date and 15.7% over the past year, which can influence how you think about upside and risk. Recent coverage around Cabot has focused on giving investors evergreen context...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

Is Alkami Technology (ALKT) Starting To Look Attractive After A 40% One-Year Share Price Fall

If you are wondering whether Alkami Technology at around US$16.75 is starting to look like value or still carries more risk than reward, the recent price history gives you a useful starting point. The stock has moved 2.0% over the last 7 days, is roughly flat over 30 days with a 0.2% decline, but is down 26.1% year to date and 40.2% over the past year, set against a 28.8% gain over 3 years and a 48.7% decline over 5 years. These mixed returns have kept attention on how the business is being...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

Is It Too Late To Consider Patrick Industries (PATK) After Recent 30 Day Share Price Slide?

Wondering if Patrick Industries, at a last close of US$95.90, offers good value or if the easy money has already been made? These valuation checks aim to give you a clearer picture before you decide your next move. The stock has had a mixed run, with a 2.8% return over the last 7 days, a 15.8% decline over 30 days, a 20.0% return over 1 year, and 132.9% over 3 years. Recent news coverage has focused on Patrick Industries as part of broader discussions around the Auto Components sector and...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

Is It Time To Reassess ADP (ADP) After Its 30% One-Year Share Price Slide

If you are wondering whether Automatic Data Processing (ADP) looks attractively priced after a rough patch, this article will help you assess what you might really be paying for with the stock. At a last close of US$207.20, ADP's share price reflects a 3.7% decline over the past week, a 1.4% gain over the past month, and returns of an 18.1% decline year to date and a 30.4% decline over the past year. Those moves have kept ADP on many investors' watchlists, with recent headlines keeping...
NasdaqGS:APEI
NasdaqGS:APEIConsumer Services

American Public Education Uses APUS Milestone To Highlight Growth Story

American Public University System, part of American Public Education (NasdaqGS:APEI), is preparing its 30th annual commencement. The ceremony includes a record graduating class for APUS. APUS is adding a dedicated doctoral hooding event and expanded graduate celebrations. Additional ceremonies and student recognition initiatives are planned around the commencement. American Public Education, through APUS, focuses on online higher education for adult learners, including military and public...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Is It Too Late To Consider Fortrea Holdings (FTRE) After Its Recent Share Price Surge?

If you are wondering whether Fortrea Holdings at US$15.64 is still offering value after a strong run, or if you are late to the story, this article focuses on what the current price might be implying. The stock has moved sharply, with returns of 48.1% over the last 7 days, 73.6% over the last 30 days and 177.8% over the last year, although year to date it sits at a 7.0% decline. Recent market attention has centered on Fortrea's position within the life sciences and pharmaceutical services...
NYSE:CW
NYSE:CWAerospace & Defense

Is It Too Late To Consider Curtiss-Wright (CW) After A 105% One-Year Rally?

Investors may be wondering whether Curtiss-Wright still offers good value after a strong share price performance, or if the current price has moved ahead of what the underlying business might justify. The stock last closed at US$742.89, with returns of 6.7% over 7 days, 6.3% over 30 days, 29.8% year to date and 105.5% over 1 year. These figures naturally raise questions about how much of the company’s story may already be reflected in the price. Recent attention on Curtiss-Wright has...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

FDA Recall Puts Merit Medical Quality Controls And Growth Story In Focus

Arrow International issued a nationwide recall of certain dialysis catheter kits that include Merit Medical’s 16F Dual-Valved Splittable Sheath Introducers. The recall is linked to a design defect that may prevent the sheath from splitting as intended during use. The action centers on product quality and regulatory compliance risks that could affect NasdaqGS:MMSI. Merit Medical Systems (NasdaqGS:MMSI) supplies devices used across interventional cardiology, radiology, and vascular access,...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

3 Growth Stocks Insiders Are Betting On

Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership often attract attention as they suggest confidence from those closest to the business and potential for sustained performance.
NYSE:RSKD
NYSE:RSKDSoftware

Cricut And 2 Other Penny Stocks With Promising Potential

Over the last 7 days, the United States market has risen 3.2%, and over the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks with strong financials can be key to capturing growth potential. Although the term "penny stocks" might seem outdated, these investments in smaller or newer companies continue to offer intriguing opportunities for those seeking affordability and potential growth.
NasdaqGS:CFFN
NasdaqGS:CFFNBanks

Discovering US Market's Undiscovered Gems in May 2026

Over the last 7 days, the United States market has risen by 3.2% and is up 31% over the last year, with earnings forecast to grow by 16% annually. In this thriving environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking undiscovered gems.